Bronchoscopy Clinical Trial
Official title:
Incidence and Nature of Respiratory Impairment in Consecutive Patients Undergoing Bronchoscopy Under Conscious Sedation: A Pilot Study
This study aims to characterize airflow patterns during bronchoscopy under conscious sedation, and determine the incidence of obstructive and central respiratory events. The investigators also plan to monitor the degree and frequency of oxygen desaturation throughout the procedure. To achieve this, investigators use a physiologic monitoring device (NOX T3, K082113) that has been FDA approved for the screening and diagnosis of sleep disordered breathing [1]. The results from this pilot study will be used to assess the feasibility of a prospective study utilizing continuous external negative pressure (Pneuway). This negative pressure is applied through a neck mask to alleviate upper airway collapsibility and can potentially decrease the number of apneas during bronchoscopy under conscious sedation [2].
Background and Rationale:
Diagnostic bronchoscopic procedures are commonly performed in patients with various forms of
pulmonary disorders associated with abnormal chest imaging. During these procedures, the
vocal cords are intubated using a flexible scope. Patients need sedation and analgesia, and
conscious sedation is typically administered. Hypoxemia is a potential complication during
bronchoscopy. Contributing factors in addition to the underlying lung pathology, include
depression of the respiratory center and decreased upper airway muscle tone that occur during
conscious sedation [3]. Upper airway obstruction including obstructive apnea is often
unrecognized during these procedures till hypoxemia is apparent [4]. Propofol, a common drug
used for conscious sedation, is known to cause respiratory depression, and potentially
central and/or obstructive apneas with a direct dose-response pattern [5]. Others, including
benzodiazepines and opiates, can also cause respiratory depression leading to central or
obstructive events. Respiratory depression is potentiated when any of the above medications
are combined [6].
Objectives:
The objective of the study is to identify the incidence of airflow limitation during
bronchoscopy under conscious sedation, and further characterize it as obstructive or central.
The primary endpoint is the incidence of obstructive and central apneic events during
bronchoscopic procedures. The secondary outcomes include incidence of oxygen desaturation and
need for escalation of care.
Study Design:
After informed consent is obtained, the NOX-T3 monitoring system, a commonly used portable
sleep device that detects obstructive and central apneas, is placed prior to starting the
procedure, and remains in place up to 30 minutes following the procedure. The NOX-T3
monitoring system includes a nasal cannula that sits over the nares, an elastic band that
goes around the chest, and another one that goes around the abdomen, and a finger probe that
is placed on the index finger. All subjects undergo bronchoscopy with standard of care
including the monitoring of blood pressure, respiratory rate and oxygen saturation. All
subjects have the NOX-T3 applied in addition to standard of care monitoring. Data is assessed
following the completion of the procedure. Subjects' participation in this study ends at the
completion of their standard of care visit. All the NOX-T3 studies are scored and interpreted
by study investigators.
Data Management:
This is an observational and descriptive study with an estimated sample size of 30. Data
collected will be reviewed with a statistician and investigators will report on patients'
demographics. The study investigators will also present the incidence of apneic respiratory
events and characterize them as obstructive or centrals. Investigators will further
differentiate obstructive respiratory events to either apneas or hypopnea. Data on oxygen
desaturations unrelated to apneic events will also be recorded.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03581474 -
Evaluation of BAL Procedure With Ambu aScope 3 Large in Patients in an ICU Setting
|
N/A | |
Completed |
NCT03294213 -
Prospective Non-interventional Evaluation of Intubation and Intensive Care Use of the New aScope™ 4 Broncho and aView
|
||
Completed |
NCT06116955 -
The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy
|
||
Withdrawn |
NCT03613792 -
Remifentanil Plus Ketamine for Dynamic Flexible Bronchoscopy
|
Phase 4 | |
Completed |
NCT04016480 -
HFNC During Bronchoscopy for Bronchoalveolar Lavage
|
N/A | |
Recruiting |
NCT01100554 -
Upper Airway Collapsibility Evaluation in Different Sedative Levels by Sleep Endoscopy
|
N/A | |
Completed |
NCT00861835 -
Trial of Rapid On-Site Evaluation of Transbronchial Needle Aspirate (TBNA)
|
N/A | |
Completed |
NCT05154916 -
The Effect of Virtual Reality Based Relaxation Program on Patients to be Performed Bronchoscopy
|
N/A | |
Completed |
NCT03086408 -
Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Diagnostic Bronchoscopy
|
N/A | |
Active, not recruiting |
NCT04884061 -
Narrow Band Imaging Bronchoscopy During SARS-CoV2 Infection
|
||
Completed |
NCT05875662 -
Pulmonary Ventilation After Fiberoptic Bronchoscopy Using EIT
|
||
Completed |
NCT00684684 -
Safety and Feasibility Study of the Chartis System
|
Phase 1 | |
Completed |
NCT03521505 -
Dexmedetomidine for Sedation of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
|
Phase 4 | |
Not yet recruiting |
NCT03856073 -
The Training and Evaluate Effect on Clinical Airway Management for Novices.
|
N/A | |
Not yet recruiting |
NCT03854760 -
The Training and Evaluate Effect on Clinical Airway Management
|
N/A | |
Recruiting |
NCT05912985 -
Three Different Oxygenation Strategies in Bronchoscopy Procedures Under Sedation
|
||
Enrolling by invitation |
NCT05692362 -
Measure Airway Compliance by Endobronchial Optical Coherence Tomography
|
||
Completed |
NCT03419546 -
Clinical Validation Trial of a Single-use Bronchoscope (Ambu® aScope ™ 4)
|
||
Not yet recruiting |
NCT03983915 -
Sedation Strategies for Therapeutic Bronchoscopy 2
|
N/A | |
Not yet recruiting |
NCT03983889 -
Sedation Strategies for Diagnostic Bronchoscopy 2
|
N/A |